| Product Code: ETC7647207 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market - Industry Life Cycle |
3.4 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market - Porter's Five Forces |
3.5 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
4 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in Israel |
4.2.2 Growing demand for personalized cancer treatments |
4.2.3 Advancements in immunotherapy research and development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug discovery and development |
4.3.2 High cost associated with immunotherapy drug discovery outsourcing |
4.3.3 Limited availability of skilled professionals in the field |
5 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Trends |
6 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market, By Types |
6.1 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Service Type, 2021- 2031F |
6.1.3 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Target Identification and Validation, 2021- 2031F |
6.1.4 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Lead Screening and Characterization, 2021- 2031F |
6.1.5 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Cell-based Assays, 2021- 2031F |
6.2 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Lung, 2021- 2031F |
6.2.3 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Breast, 2021- 2031F |
6.2.4 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Colorectal, 2021- 2031F |
6.2.5 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.2.6 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Prostate, 2021- 2031F |
6.2.7 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Head and Neck, 2021- 2031F |
6.3 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.3.3 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Immunomodulators, 2021- 2031F |
6.3.4 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Cancer Vaccines and Oncolytic Viral Therapy, 2021- 2031F |
7 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Import-Export Trade Statistics |
7.1 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Export to Major Countries |
7.2 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Imports from Major Countries |
8 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Key Performance Indicators |
8.1 Number of clinical trials utilizing immunotherapy drugs in Israel |
8.2 Investment in cancer immunotherapy research and development in Israel |
8.3 Number of partnerships between Israeli research institutions and pharmaceutical companies in the field |
9 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market - Opportunity Assessment |
9.1 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market - Competitive Landscape |
10.1 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Share, By Companies, 2024 |
10.2 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here